Poor bone health with related morbidity is a major problem with Duchene Muscular Dystrophy (DMD). Decreased mobility and long-term corticosteroid therapy are involved in poor bone health in DMD. We investigated bone mineral density and bone metabolism in 30 steroid treated DMD patients and also compared mentioned factors between ambulated and non-ambulated patients.
Read the full research article and you will find why I’m so excited
- Forums
- ASX - By Stock
- PER
- Ann: ATL1102 Data presented at MDA Annual Conference
PER
percheron therapeutics limited
Add to My Watchlist
0.00%
!
0.9¢

Ann: ATL1102 Data presented at MDA Annual Conference, page-9
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.786M |
Open | High | Low | Value | Volume |
1.0¢ | 1.0¢ | 0.9¢ | $8.6K | 910K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 499999 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 8734157 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 499999 | 0.009 |
25 | 6627862 | 0.008 |
8 | 3079427 | 0.007 |
3 | 1950000 | 0.006 |
2 | 699800 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 8734157 | 12 |
0.011 | 3640661 | 6 |
0.012 | 2608324 | 4 |
0.013 | 1300000 | 2 |
0.014 | 1500000 | 2 |
Last trade - 16.10pm 01/08/2025 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ron Miller, Non-Executive Director
Ron Miller
Non-Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online